A detailed history of Camden Capital, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Camden Capital, LLC holds 4,073 shares of MDT stock, worth $328,854. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,073
Previous 3,447 18.16%
Holding current value
$328,854
Previous $271,000 35.06%
% of portfolio
0.04%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.84 - $91.03 $48,101 - $56,984
626 Added 18.16%
4,073 $366,000
Q2 2024

Aug 06, 2024

BUY
$78.71 - $87.02 $271,313 - $299,957
3,447 New
3,447 $271,000
Q4 2023

Feb 05, 2024

BUY
$69.43 - $83.43 $57,835 - $69,497
833 Added 28.68%
3,737 $307,000
Q3 2023

Nov 03, 2023

BUY
$78.22 - $90.4 $21,197 - $24,498
271 Added 10.29%
2,904 $227,000
Q2 2023

Aug 09, 2023

BUY
$79.47 - $91.38 $209,244 - $240,603
2,633 New
2,633 $231,000
Q4 2021

Feb 14, 2022

SELL
$99.53 - $127.75 $109,980 - $141,163
-1,105 Reduced 20.77%
4,216 $436,000
Q3 2021

Nov 03, 2021

BUY
$122.75 - $135.17 $176,023 - $193,833
1,434 Added 36.89%
5,321 $667,000
Q2 2021

Aug 16, 2021

BUY
$118.19 - $131.5 $44,557 - $49,575
377 Added 10.74%
3,887 $483,000
Q1 2021

May 10, 2021

SELL
$111.18 - $119.74 $4,780 - $5,148
-43 Reduced 1.21%
3,510 $415,000
Q4 2020

Feb 04, 2021

BUY
$100.57 - $117.14 $30,372 - $35,376
302 Added 9.29%
3,553 $416,000
Q3 2020

Oct 30, 2020

BUY
$90.13 - $108.78 $44,614 - $53,846
495 Added 17.96%
3,251 $338,000
Q2 2020

Aug 11, 2020

SELL
$84.11 - $103.33 $169,818 - $208,623
-2,019 Reduced 42.28%
2,756 $253,000
Q1 2020

Apr 13, 2020

SELL
$72.92 - $121.3 $26,542 - $44,153
-364 Reduced 7.08%
4,775 $436,000
Q4 2019

Feb 10, 2020

BUY
$104.49 - $114.54 $536,974 - $588,621
5,139 New
5,139 $583,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $107B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.